211 related articles for article (PubMed ID: 28442578)
21. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
[TBL] [Abstract][Full Text] [Related]
22. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
Klimek L; Bachert C; Stjärne P; Dollner R; Larsen P; Haahr P; Agache I; Scadding G; Price D
Allergy Asthma Proc; 2016 Sep; 37(5):376-86. PubMed ID: 27657521
[TBL] [Abstract][Full Text] [Related]
23. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
[TBL] [Abstract][Full Text] [Related]
24. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
[TBL] [Abstract][Full Text] [Related]
25. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
[TBL] [Abstract][Full Text] [Related]
26. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L; Bousquet J; Price D
Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
[TBL] [Abstract][Full Text] [Related]
27. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
[TBL] [Abstract][Full Text] [Related]
29. Azelastine and fluticasone nasal spray: any advantage?
Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
[TBL] [Abstract][Full Text] [Related]
31. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
[TBL] [Abstract][Full Text] [Related]
32. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
33. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
[TBL] [Abstract][Full Text] [Related]
36. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
[No Abstract] [Full Text] [Related]
37. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
38. The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.
Bjermer L; Westman M; Holmström M; Wickman MC
Allergy Asthma Clin Immunol; 2019; 15():24. PubMed ID: 31015846
[TBL] [Abstract][Full Text] [Related]
39. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.
Roca-Ferrer J; Pujols L; Pérez-González M; Alobid I; Callejas B; Vicens-Artés S; Fuentes M; Valero A; Picado C; Castor D; Nguyen D; Mullol J
Allergy Asthma Clin Immunol; 2018; 14():86. PubMed ID: 30574167
[TBL] [Abstract][Full Text] [Related]
40. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
Carr W; Bernstein J; Lieberman P; Meltzer E; Bachert C; Price D; Munzel U; Bousquet J
J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]